Intraoperative Radiotherapy in the Management of Locally Recurrent Extremity Soft Tissue Sarcoma

Autor: Braunstein, Steve, Tinkle, CL, Weinberg, V, Braunstein, SE, Wustrack, R, Horvai, A, Jahan, T, O'Donnell, RJ, Gottschalk, AR

Publikováno v: Braunstein, Steve; Tinkle, CL; Weinberg, V; Braunstein, SE; Wustrack, R; Horvai, A; et al.(2015). Intraoperative Radiotherapy in the Management of Locally Recurrent Extremity Soft Tissue Sarcoma. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/3819w021

© 2015 Christopher L. Tinkle et al.Purpose. To investigate the efficacy and morbidity of limb-sparing surgery with intraoperative radiotherapy (IORT) for patients with locally recurrent extremity soft tissue sarcoma (ESTS). Methods and Materials. Tw

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::255dab39e61f5cae48935cf1697c89a8
http://www.escholarship.org/uc/item/3819w021

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology.

Autor: Rahman R; Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Shi DD; Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Reitman ZJ; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA., Hamerlik P; Division of Cancer Sciences, University of Manchester, Manchester, UK., de Groot JF; Division of Neuro-Oncology, University of California San Francisco, San Francisco, California, USA., Haas-Kogan DA; Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., D'Andrea AD; Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Sulman EP; Department of Radiation Oncology, New York University, New York, New York, USA., Tanner K; National Brain Tumor Society, Newton, Massachusetts, USA., Agar NYR; Department of Neurosurgery and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Sarkaria JN; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA., Tinkle CL; Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Bindra RS; Department of Therapeutic Radiology, Yale University, New Haven, Connecticut, USA., Mehta MP; Miami Cancer Institute, Baptist Hospital, Miami, Florida, USA., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

Publikováno v: Neuro-oncology [Neuro Oncol] 2024 Aug 05; Vol. 26 (8), pp. 1367-1387.

PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma.

Autor: Duchatel RJ; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia., Jackson ER; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia., Parackal SG; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia., Kiltschewskij D; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., Findlay IJ; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia., Mannan A; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Staudt DE; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia., Thomas BC; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia., Germon ZP; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Laternser S; DIPG/DMG Research Center Zurich, Children's Research Center, Department of Pediatrics, University Children's Hospital Zürich, Zurich, Switzerland., Kearney PS; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Jamaluddin MFB; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., Douglas AM; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Beitaki T; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., McEwen HP; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Persson ML; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia., Hocke EA; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA., Jain V; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA., Aksu M; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA., Manning EE; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., Murray HC; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., Verrills NM; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., Sun CX; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia., Daniel P; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia., Vilain RE; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Skerrett-Byrne DA; Infertility and Reproduction Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Nixon B; Infertility and Reproduction Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Hua S; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., de Bock CE; Children's Cancer Institute, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia.; School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia., Colino-Sanguino Y; Children's Cancer Institute, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia.; School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia., Valdes-Mora F; Children's Cancer Institute, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia.; School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia., Tsoli M; Children's Cancer Institute, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia.; School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia., Ziegler DS; Children's Cancer Institute, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia.; School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia.; Kids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia., Cairns MJ; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., Raabe EH; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Vitanza NA; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA.; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA., Hulleman E; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Phoenix TN; Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA., Koschmann C; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA., Alvaro F; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; John Hunter Children's Hospital, New Lambton Heights, New South Wales, Australia., Dayas CV; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., Tinkle CL; Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Wheeler H; Department of Radiation Oncology Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, New South Wales, Australia.; The Brain Cancer group, St Leonards, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, Australia., Whittle JR; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia., Eisenstat DD; Children's Cancer Centre, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.; Neuro-Oncology Laboratory, Murdoch Children's Research Institute, Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia., Firestein R; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia., Mueller S; DIPG/DMG Research Center Zurich, Children's Research Center, Department of Pediatrics, University Children's Hospital Zürich, Zurich, Switzerland.; Department of Neurology, Neurosurgery, and Pediatrics, University of California, San Francisco, California, USA., Valvi S; Department of Paediatric and Adolescent Oncology/Haematology, Perth Children's Hospital, Nedlands, Washington, Australia.; Brain Tumour Research Laboratory, Telethon Kids Institute, Nedlands, Washington, Australia.; Division of Paediatrics, University of Western Australia Medical School, Nedlands, Western Australia, Australia., Hansford JR; Michael Rice Centre for Hematology and Oncology, Women's and Children's Hospital, North Adelaide, South Australia, Australia.; South Australia Health and Medical Research Institute, Adelaide, South Australia, Australia.; South Australian Immunogenomics Cancer Institute, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia., Ashley DM; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University, Durham, North Carolina, USA., Gregory SG; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA.; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University, Durham, North Carolina, USA., Kilburn LB; Center for Genetic Medicine Research, Children's National Hospital, Washington, DC, USA.; The George Washington University, School of Medicine and Health Sciences, Washington, DC, USA., Nazarian J; DIPG/DMG Research Center Zurich, Children's Research Center, Department of Pediatrics, University Children's Hospital Zürich, Zurich, Switzerland.; Center for Genetic Medicine Research, Children's National Hospital, Washington, DC, USA.; The George Washington University, School of Medicine and Health Sciences, Washington, DC, USA., Cain JE; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia., Dun MD; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2024 Feb 06; Vol. 134 (6). Date of Electronic Publication: 2024 Feb 06.

Correlation between Multiparametric MR Imaging and Molecular Genetics in Pontine Pediatric High-Grade Glioma.

Autor: Rameh V; From the Department of Radiology (V.R., S.V., A.Z., T.Y.P.), Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Vajapeyam S; From the Department of Radiology (V.R., S.V., A.Z., T.Y.P.), Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Ziaei A; From the Department of Radiology (V.R., S.V., A.Z., T.Y.P.), Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Kao P; Department of Pediatric Oncology (P.K., W.B.L., K.D.W.), Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., London WB; Department of Pediatric Oncology (P.K., W.B.L., K.D.W.), Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Baker SJ; Departments of Developmental Neurobiology (S.J.B.)., Chiang J; Pathology (J.C.)., Lucas J; Radiation Oncology (J.L., C.L.T.), St. Jude Children's Research Hospital, Memphis, Tennessee., Tinkle CL; Radiation Oncology (J.L., C.L.T.), St. Jude Children's Research Hospital, Memphis, Tennessee., Wright KD; Department of Pediatric Oncology (P.K., W.B.L., K.D.W.), Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Poussaint TY; From the Department of Radiology (V.R., S.V., A.Z., T.Y.P.), Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts tinayoung.poussaint@childrens.harvard.edu.

Publikováno v: AJNR. American journal of neuroradiology [AJNR Am J Neuroradiol] 2023 Jul; Vol. 44 (7), pp. 833-840. Date of Electronic Publication: 2023 Jun 15.